Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For TSLA.NE
Valuation Bad
0%
Profitability n.A.
Fin. Growth Positive
67%
Leverage & Liquidity Weak
33%
Per Share Metrics Positive
67%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio -0.59 1.72 1.73
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 66.37 -0.66 -1.96
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 12.43 1.48 1.32
Cash 1.00 0.62 0.61
Capex -31.67 -0.06 -0.05
Free Cash Flow 34.41 -0.06 0.04
Revenue -7.42 0.49 0.53
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -1.60 0.17 0.18
Operating Margin -32.97 0.05 0.08
ROA -86.10 0.01 0.07
ROE -86.15 0.02 0.13
ROIC -88.79 0.01 0.10
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of TSLA.NE is permitted for members.
5 Growth
The "Growth Entry" for the Focus of TSLA.NE is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of TSLA.NE is permitted for members.